Tacrolimus rescue therapy for renal allograft rejection refractory to cyclosporine-based immunosuppression.
Washburn
W K
WK
Division of Organ Transplantation, New England Deaconness Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Shaffer
D
D
Simpson
M A
MA
Conway
P
P
Madras
P N
PN
Monaco
A P
AP
D000208:Acute Disease; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D001786:Blood Glucose / Q000378:metabolism; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D006084:Graft Rejection / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D008297:Male; D016035:Pancreas Transplantation / Q000276:immunology / Q000502:physiology; D011241:Prednisone / Q000627:therapeutic use; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D001379:Azathioprine; D001786:Blood Glucose; D016572:Cyclosporine; D006442:Glycated Hemoglobin; D007166:Immunosuppressive Agents; D011241:Prednisone; D016559:Tacrolimus